RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX)

Filing Manager: RA CAPITAL MANAGEMENT, L.P.
Reporting Manager: RA Capital Management, L.P.
Security: Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share
Symbol: RXRX
Shares outstanding: 386,254,800 shares
Disclosed Ownership: 7,725,096 shares
Ownership: 2%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 18:41:24 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
RA Capital Management, L.P.	2%	7,725,096	7,725,096	/s/ Peter Kolchinsky	By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky	2%	7,725,096	7,725,096	/s/ Peter Kolchinsky	Peter Kolchinsky
Rajeev Shah	2%	7,725,096	7,725,096	/s/ Rajeev Shah	Rajeev Shah
RA Capital Healthcare Fund, L.P.	2%	7,725,096	7,725,096	/s/ Peter Kolchinsky	By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager